Home » Authors » Cynthia Robbins-Roth

Articles by Cynthia Robbins-Roth

Opening The Risk Debate Crucial For Biotech's Future

Jan. 29, 2007

By Cynthia Robbins-Roth

Opening The Risk Debate Crucial For Biotech's Future

Jan. 29, 2007

By Cynthia Robbins-Roth

Research at Gladstone Institute Translating Into New Products

Jan. 16, 2007

By Cynthia Robbins-Roth

Research at Gladstone Institute Translating Into New Products

Jan. 16, 2007

By Cynthia Robbins-Roth

Unintended Consequences: Mother Nature vs. Innovation

Jan. 2, 2007

By Cynthia Robbins-Roth

Unintended Consequences: Mother Nature vs. Innovation

Jan. 2, 2007

By Cynthia Robbins-Roth

Weak Dollar Good For Biotech: Outsourcing Trend May Reverse

Dec. 18, 2006

By Cynthia Robbins-Roth

Weak Dollar Good For Biotech: Outsourcing Trend May Reverse

Dec. 18, 2006

By Cynthia Robbins-Roth

Will 2007 Have Tidings Of Joy? Some Thoughts On Next Year

Dec. 4, 2006

By Cynthia Robbins-Roth

Will 2007 Have Tidings Of Joy? Some Thoughts On Next Year

Dec. 4, 2006

By Cynthia Robbins-Roth

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...